A Drug Company Made $114 Billion Gaming America’s Patent System by adding tiny bits to the original patent
The New York Times looks at the AbbVie’s anti-inflammatory drug Humira and their “savvy but legal exploitation of the U.S. patent system.” Though AbbVie’s patent was supposed to expire in 2016, since then it’s maintained a monopoly that generated $114 billion in revenue by using “a formidable wall of intellectual property protection and suing would-be Read more about A Drug Company Made $114 Billion Gaming America’s Patent System by adding tiny bits to the original patent[…]